English
Chinese
Last October, a contract manufacturer in Minnesota got a 483 observation during an FDA pre-approval inspection. The finding: “Failure to establish and maintain procedures for verifying the acceptability of supplier-provided product.” The product in question? Their cleanroom wipes. Not the implant. Not the packaging material. The wipe they’d been using on the assembly bench for three years without a single documented incoming inspection.
It sounds almost absurd—until you realize how common this is. We’ve talked to quality directors at medtech plants across North America, Europe, and Asia who’ve had similar experiences. A Notified Body auditor in Tüv Rheinland asks for the CoA on your cleanroom wipes and gets a blank stare. An FDA investigator pulls your consumable qualification file and finds a purchase order and nothing else. A customer audit flags your wipe supplier as unqualified in your Approved Supplier List.
The wipe itself isn’t usually the problem. The documentation around it is. And in a medical device facility governed by ISO 13485 and FDA 21 CFR Part 820, documentation gaps on consumables are the same as documentation gaps on raw materials—at least in the eyes of an auditor.
This article isn’t about how to pick the right wipe material. We covered that in our medical devices cleanroom consumables guide. This is about what happens when your wipe program meets an auditor—and how to make sure it goes well.
The Wipe-Related Findings We Keep Seeing
FDA 483 observations and Notified Body nonconformances related to cleanroom consumables tend to cluster around a few recurring themes. If you’re a quality manager at a medical device plant, odds are you’ve seen at least one of these—or you will.
No supplier qualification on file. The company buys wipes from a distributor, has a purchase order, maybe a generic spec sheet from the distributor’s website, but no formal evaluation of the supplier’s quality system. No audit, no quality agreement, no documented qualification rationale. Under ISO 13485 Clause 7.4 and FDA §820.50, that’s a gap. The auditor doesn’t care that you’ve been buying the same wipe for five years without a problem—they care that you can’t demonstrate you evaluated the supplier’s ability to meet your requirements.
Missing or generic Certificates of Analysis. The supplier provides a “certificate” that says the product “meets specification” without listing actual test data. Or they provide a batch certificate that covers a production run spanning multiple lots. Auditors want per-lot CoAs with specific test results for particle count, NVR, extractable ions, and bioburden—matched against the acceptance criteria in your incoming inspection procedure. If the CoA doesn’t have numbers, it’s not a CoA.
Incoming inspection that doesn’t actually inspect. Some facilities have an incoming inspection procedure on paper but in practice just file the CoA without verifying it against their own acceptance criteria. The procedure says “verify lot-specific CoA against purchasing spec,” but nobody’s checking whether the particle count on the CoA actually falls within the spec limits. That’s a procedural nonconformance—it doesn’t matter that the data would have passed if someone had looked at it.
No change control from the supplier. The wipe supplier switches their raw material source or changes their irradiation provider and doesn’t tell you. Six months later, during a CAPA investigation into a particulate contamination event, you discover the wipe’s extractable profile has changed. Your process validation was based on the old material. Now you’re looking at a retrospective impact assessment and potentially revalidation work. All because nobody built change notification requirements into the supplier agreement.
Wipe lot numbers not traced in batch records. This one’s insidious because it only matters when something goes wrong. A contamination event triggers an investigation. The quality team wants to correlate the event with specific consumable lots. But the Device History Record doesn’t track wipe lot numbers—just “cleanroom wipes used per SOP.” Now your investigation has a dead end, and your CAPA is weaker for it.
What Auditors Actually Ask for (And What They Write Up When You Can’t Produce It)
Knowing what auditors look for is half the battle. Here’s what we’ve seen come up in real inspections and audits, organized by the question they ask and the finding they write when the answer is inadequate.
“Show me your Approved Supplier List for consumables.”
They want to see your wipe supplier listed, with a documented qualification date and the basis for qualification. If the supplier isn’t on the list, or if they’re on the list but there’s no qualification record behind the entry, that’s an observation under §820.50 or ISO 13485 Clause 7.4.1.
“Show me the purchasing specifications for your cleanroom wipes.”
They want a document that defines what you’re buying—material composition, particle count limits, NVR limits, bioburden limits, extractable ion limits, edge treatment, size, fold, packaging requirements. If your “specification” is a distributor’s part number on a purchase order, that’s not a specification. It’s an order form.
“Show me the CoA for the lot currently in use.”
They want a lot-specific CoA with actual test data that matches your purchasing spec’s acceptance criteria. They may cross-reference the lot number on the CoA with the lot number in your incoming inspection record and the lot number recorded in the Device History Record for current production batches. If any of these don’t connect, you’ve got a traceability gap.
“Show me your incoming inspection procedure and records.”
They want a procedure that defines what you check (CoA review at minimum, possibly sample testing), what the acceptance criteria are, and what you do when a lot fails. Then they want records showing you actually followed the procedure for every incoming lot. A procedure nobody follows is worse than no procedure—it demonstrates that you knew the requirement and chose not to meet it.
“Have you had any contamination events traceable to consumables?”
If you have, they want to see the investigation, the root cause determination, and the CAPA. If you haven’t, they may still ask how you would handle one—testing whether your CAPA procedure covers consumable-related events. If your CAPA procedure only references raw materials and processes but doesn’t mention consumables, that’s a soft finding that signals a gap in your quality system.
When a Wipe Triggers a CAPA: Real Scenarios
CAPAs triggered by cleanroom consumable issues aren’t theoretical. Here are scenarios we’ve encountered or heard about from quality teams in the field:
Particulate contamination on a bonding surface. A catheter manufacturer found fibers on adhesive bonding zones during in-process inspection. Investigation traced the fibers to a new lot of wipes that had a different fiber structure than the previous lot—the supplier had changed their manufacturing process without notification. The CAPA required incoming inspection procedure revision, supplier agreement update to include change notification requirements, and a retrospective review of product manufactured during the gap period. Total cost: three months of investigation and revalidation work.
Failed biocompatibility testing linked to extractables. A manufacturer of an implantable device received cytotoxicity failures during routine biocompatibility per ISO 10993-5. After extensive investigation, the root cause was traced to extractables from a wipe used during final surface cleaning. The wipe’s NVR had increased due to a change in the supplier’s raw material. The CAPA involved switching to a certified low-extractable wipe, re-validating the cleaning process, and adding NVR testing to incoming inspection. The product launch was delayed by four months.
Audit finding for missing CoAs. During a Notified Body surveillance audit, the auditor requested CoAs for the cleanroom wipes used in a Class III device assembly area. The quality team produced a generic “batch certificate” without per-lot data. The finding was classified as a minor nonconformance, but it triggered a systemic review of all consumable documentation. The corrective action required qualifying the supplier under the QMS, establishing per-lot CoA requirements, and training incoming inspection personnel.
Cross-contamination from improper zone segregation. A facility used the same wipe type in both an ISO Class 7 ante-room and an ISO Class 5 critical zone. During an environmental monitoring excursion investigation, the wipes were identified as a potential contamination vector—they were being carried from the ante-room into the critical zone without any controls. The CAPA required zone-specific wipe procurement, color-coded packaging, and SOP revisions for consumable handling in classified areas.
Building an Audit-Ready Wipe Program from Scratch
If you’re starting from nothing—or rebuilding after a finding—here’s the framework we recommend. It’s the same approach we’ve seen work at facilities that pass audits cleanly.
Step 1: Write a Purchasing Specification
Define what you need in a document that lives in your QMS. Material composition, particle count limits (referencing IEST-RP-CC004.4), NVR limits, extractable ion limits, bioburden limits, edge treatment, size, fold, packaging, and sterilization requirements if applicable. This becomes the benchmark against which you evaluate every incoming lot and every potential new supplier.
Step 2: Qualify the Supplier
Evaluate the supplier’s quality system. Request their quality manual or equivalent, review their manufacturing process, assess their change control procedures, and verify their testing capabilities. Document the evaluation and add them to your Approved Supplier List with a qualification date and rationale. If you accept a third-party audit report (e.g., ISO 9001 certification), document that as the basis for qualification.
Step 3: Establish Incoming Inspection
Write a procedure that specifies what you check for every incoming lot: lot-specific CoA review against your purchasing spec’s acceptance criteria, visual inspection of packaging integrity, and any sample testing your risk assessment warrants. Define acceptance criteria, rejection criteria, and the disposition process for non-conforming lots. Then actually follow it—every lot, every time.
Step 4: Build Traceability into Batch Records
Add wipe lot numbers to your Device History Record or equivalent batch record. This doesn’t have to be complicated—a field for “consumable lot numbers used” alongside operator initials and date. The value shows up during investigations: when a contamination event occurs, you can immediately correlate it with specific consumable lots and narrow the scope of your CAPA.
Step 5: Define Change Control Requirements
Include change notification clauses in your Supplier Quality Agreement. The supplier must notify you before— not after—changing raw material sources, manufacturing processes, sterilization providers, or testing methods. Define the notification timeline (e.g., 90 days advance notice) and your right to evaluate the impact on your validated processes before the change takes effect.
Step 6: Train Your People
Your incoming inspection team needs to know what a legitimate CoA looks like and what to do when one doesn’t meet spec. Your production operators need to understand why they’re recording wipe lot numbers in batch records. Your procurement team needs to know that buying consumables for a regulated facility isn’t the same as buying office supplies. Training records are audit evidence—document it all.
The Team Behind WIPESTAR’s Medical Device Support
WIPESTAR manufactures cleanroom consumables from our facility in Shenzhen, China. We’ve been in this business for over a decade, and we work with semiconductor fabs, pharmaceutical plants, and an expanding base of medical device manufacturers who need consumables that hold up under regulatory scrutiny.
When you work with us, here’s who you’ll deal with:
Ethan leads sales. Twenty-plus years in cleanroom consumables, with direct experience supporting medtech procurement teams through supplier qualification. He knows what auditors look for because he’s helped clients prepare for those audits.
Lee manages key accounts. He spent seven years before joining WIPESTAR working with Foxconn, Samsung, and Apple—companies whose supplier qualification standards are among the toughest in the industry. If your quality team has questions about documentation requirements, Lee has answers.
Juan specializes in purification and cleanroom environments. He’s been involved in cleanroom design and validation projects and brings that facility-level perspective to conversations about contamination control strategy.
Guan bridges semiconductor and medical device cleanroom requirements. After 4.5 years in semiconductors and 5+ years in cleanroom consumables, he understands the particulate control overlap between the two industries.
Carolina works on the production floor with our raw material suppliers. She’s the quality link in the chain—making sure every lot meets the specs your QMS requires before it leaves our facility.
Full team on our team page.
We provide per-lot CoAs with actual test data, can build documentation packages to match your ISO 13485 incoming inspection requirements, and supply biocompatibility data, irradiation validation reports, and extractable studies on request. Custom specifications, OEM labeling, and global shipping available.
See our product range or request the full catalog.
Frequently Asked Questions
Request a Quote
Certified cleanroom wipes with audit-ready documentation. Per-lot CoAs, supplier qualification packages, biocompatibility data. Direct from our factory—bulk pricing, custom specs, global shipping.
